Abstract
目的: 综述糖尿病胰岛替代治疗的供体细胞来源及选择的研究进展。.
方法: 查阅近年来国内外关于糖尿病胰岛替代治疗及供体细胞来源的相关文献,进行总结分析。.
结果: 供体来源短缺仍是胰岛移植(pancreatic islet transplantation,PIT)面临的主要难题。目前,除同种异体/自体供胰外,异种(猪)胰岛、干细胞诱导胰岛及胰岛细胞株制备和应用等方面也取得了重要进展,潜在扩大了可植入细胞来源。.
结论: 充足、合适的供体细胞来源是临床广泛开展 PIT 治疗 1 型糖尿病(type 1 diabetes mellitus,T1DM)的前提。社会捐赠体系的完善,免疫耐受诱导、基因与生物工程等技术的发展有望解决供体细胞短缺问题,并为临床细胞替代治疗 T1DM 奠定了基础。.
| Original language | English |
|---|---|
| Pages (from-to) | 104-111 |
| Number of pages | 8 |
| Journal | Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery |
| Volume | 32 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Jan 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Islet transplantation
- donator
- stem cells
- type 1 diabetes mellitus
- xenotransplantation
Fingerprint
Dive into the research topics of 'Research progress on the donor cell sources of pancreatic islet transplantation for treatment of diabetes mellitus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver